Cresco Labs Inc
CNSX:CL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kao Corp
OTC:KAOOY
|
JP |
Cresco Labs Inc
Stock-Based Compensation
Cresco Labs Inc
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cresco Labs Inc
CNSX:CL
|
Stock-Based Compensation
$11.2m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Stock-Based Compensation
$1.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Stock-Based Compensation
$553m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
9%
|
|
|
Pfizer Inc
NYSE:PFE
|
Stock-Based Compensation
$799m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Stock-Based Compensation
$820m
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Stock-Based Compensation
$626m
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Cresco Labs Inc
Glance View
Cresco Labs Inc. engages in the business of cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois and currently employs 3,500 full-time employees. The company went IPO on 2018-12-03. The firm is the wholesaler of branded cannabis products in the United States. Its brands include Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, the Company’s national dispensary brand, is a wellness-focused retailer. The firm operates in and/ or has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, Arizona, New York, Massachusetts, Michigan and Florida.
See Also
What is Cresco Labs Inc's Stock-Based Compensation?
Stock-Based Compensation
11.2m
USD
Based on the financial report for Dec 31, 2025, Cresco Labs Inc's Stock-Based Compensation amounts to 11.2m USD.
What is Cresco Labs Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
-10%
Over the last year, the Stock-Based Compensation growth was -21%. The average annual Stock-Based Compensation growth rates for Cresco Labs Inc have been -21% over the past three years , -10% over the past five years .
